Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Vera

Showing results (101-110 of 143) with videos related to

Pageof 15
Sort By:
Entropy (Basel, Switzerland)|May 28, 2022
Correction: Brochet et al. A Quantitative Comparison between Shannon and Tsallis-Havrda-Charvat Entropies Applied to Cancer Outcome Prediction. <i>Entropy</i> 2022, <i>24</i>, 436Thibaud Brochet, Jérôme Lapuyade-Lahorgue, Alexandre Huat, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 15, 2019
Radiotherapy boost in patients with hypoxic lesions identified by <sup>18</sup>F-FMISO PET/CT in non-small-cell lung carcinoma: can we expect a better survival outcome without toxicity? [RTEP5 long-term follow-up]Pierre Vera, Sorina-Dana Mihailescu, Justine Lequesne, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 1, 2010
αvβ3 imaging can accurately distinguish between mature teratoma and necrosis in 18F-FDG-negative residual masses after treatment of non-seminomatous testicular cancer: a preclinical studyNicolas Aide, Mélanie Briand, Pierre Bohn, et al.
EJNMMI Research|November 17, 2018
A new methodology to derive 3D kinetic parametric FDG PET images based on a mathematical approach integrating an error model of measurementElyse Colard, Sarkis Delcourt, Laetitia Padovani, et al.
Plos One|July 8, 2014
Magnetic resonance colonography for fibrosis assessment in rats with chronic colitisChloé Melchior, Emilien Loeuillard, Rachel Marion-Letellier, et al.
Scientific Reports|June 5, 2023
Evaluation of the capability and reproducibility of RECIST 1.1. measurements by technologists in breast cancer follow-up: a pilot studyPierrick Gouel, Françoise Callonnec, Émilie Levêque, et al.
Biomolecules|March 25, 2020
Development of Novel <sup>111</sup>-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid TumoursBenjamin Poret, Laurence Desrues, Marc-André Bonin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 19, 2007
Does chemotherapy influence the quantification of SUV when contrast-enhanced CT is used in PET/CT in lymphoma?Pierre Vera, Matthieu John Ouvrier, Sébastien Hapdey, et al.
EJNMMI Research|March 8, 2014
Monitoring tumour response during chemo-radiotherapy: a parametric method using FDG-PET/CT images in patients with oesophageal cancerPierre Vera, Bernard Dubray, Odré Palie, et al.
Blood|April 27, 2011
SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphomaRené-Olivier Casasnovas, Michel Meignan, Alina Berriolo-Riedinger, et al.
Pageof 15

Showing results (101-110 of 143) with videos related to

Sort By:
Pageof 15
Entropy (Basel, Switzerland)|May 28, 2022
Correction: Brochet et al. A Quantitative Comparison between Shannon and Tsallis-Havrda-Charvat Entropies Applied to Cancer Outcome Prediction. <i>Entropy</i> 2022, <i>24</i>, 436Thibaud Brochet, Jérôme Lapuyade-Lahorgue, Alexandre Huat, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 15, 2019
Radiotherapy boost in patients with hypoxic lesions identified by <sup>18</sup>F-FMISO PET/CT in non-small-cell lung carcinoma: can we expect a better survival outcome without toxicity? [RTEP5 long-term follow-up]Pierre Vera, Sorina-Dana Mihailescu, Justine Lequesne, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 1, 2010
αvβ3 imaging can accurately distinguish between mature teratoma and necrosis in 18F-FDG-negative residual masses after treatment of non-seminomatous testicular cancer: a preclinical studyNicolas Aide, Mélanie Briand, Pierre Bohn, et al.
EJNMMI Research|November 17, 2018
A new methodology to derive 3D kinetic parametric FDG PET images based on a mathematical approach integrating an error model of measurementElyse Colard, Sarkis Delcourt, Laetitia Padovani, et al.
Plos One|July 8, 2014
Magnetic resonance colonography for fibrosis assessment in rats with chronic colitisChloé Melchior, Emilien Loeuillard, Rachel Marion-Letellier, et al.
Scientific Reports|June 5, 2023
Evaluation of the capability and reproducibility of RECIST 1.1. measurements by technologists in breast cancer follow-up: a pilot studyPierrick Gouel, Françoise Callonnec, Émilie Levêque, et al.
Biomolecules|March 25, 2020
Development of Novel <sup>111</sup>-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid TumoursBenjamin Poret, Laurence Desrues, Marc-André Bonin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 19, 2007
Does chemotherapy influence the quantification of SUV when contrast-enhanced CT is used in PET/CT in lymphoma?Pierre Vera, Matthieu John Ouvrier, Sébastien Hapdey, et al.
EJNMMI Research|March 8, 2014
Monitoring tumour response during chemo-radiotherapy: a parametric method using FDG-PET/CT images in patients with oesophageal cancerPierre Vera, Bernard Dubray, Odré Palie, et al.
Blood|April 27, 2011
SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphomaRené-Olivier Casasnovas, Michel Meignan, Alina Berriolo-Riedinger, et al.
Pageof 15